Balance Sheet Ipsen

Equities

IPN

FR0010259150

Pharmaceuticals

Real-time Euronext Paris Other stock markets 12:21:19 10/03/2026 +03			5-day change	1st Jan Change
161.30 ^EUR	+4.60%		+0.31%	+35.55%

03-09	Hutchmed (China) says Ipsen initiates market withdrawal and recall of Tazverik in China	RE
03-09	Hutchmed announces update on licensed oncology product Tazverik in China	RE

006927b90aea.i0fVflxgbcddkAuD5YILjoKzKl3V7WmWUgemxQ4R8zA.xwiXHGQSLJ8z4mm1pOYz-7vmGSiN3TD5JFbQp2xQnGbYFb4cbiwVqzLdUg

Published financial data: IPSEN

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	2.87B	3.02B	3.13B	3.4B	3.68B
Other Revenues, Total	130M	131M	179M	174M	253M
Total Revenues	3B	3.16B	3.31B	3.57B	3.93B
Cost of Goods Sold, Total	538M	528M	571M	619M	751M
Gross Profit	2.46B	2.63B	2.74B	2.96B	3.18B
Selling General & Admin Expenses, Total	1.03B	1.04B	1.14B	1.17B	1.16B
R&D Expenses	428M	445M	619M	687M	754M
Other Operating Expenses	82.3M	148M	120M	255M	233M
Other Operating Expenses, Total	1.55B	1.63B	1.87B	2.12B	2.15B
Operating Income	916M	996M	861M	840M	1.03B
Interest Expense, Total	-23.7M	-23.8M	-26.2M	-23.1M	-36.1M
Interest And Investment Income	2.4M	5.3M	6.8M	14.5M	28M
Net Interest Expenses	-21.3M	-18.5M	-19.4M	-8.6M	-8.1M
Income (Loss) On Equity Invest.	400K	-1.5M	-5.4M	500K	-600K
Currency Exchange Gains (Loss)	-900K	9.2M	-4.8M	-9.6M	10M
Other Non Operating Income (Expenses)	-16.3M	-17.9M	-21.9M	-39.7M	-38.8M
EBT, Excl. Unusual Items	878M	968M	810M	782M	989M
Restructuring Charges	-50.8M	-98.9M	-210M	-125M	-29.4M
Merger & Related Restructuring Charges	-	-52.7M	-89M	-	-
Gain (Loss) On Sale Of Investments	3.1M	2.6M	-8M	-6.3M	-9.4M
Gain (Loss) On Sale Of Assets	-5.8M	-	-	82M	-
Asset Writedown	-9.1M	-114M	253M	-281M	-347M
Other Unusual Items	-	-	-	-19.7M	-25.1M
EBT, Incl. Unusual Items	815M	704M	756M	432M	578M
Income Tax Expense	168M	112M	136M	74.9M	134M
Earnings From Continuing Operations	647M	592M	620M	357M	444M
Earnings Of Discontinued Operations	-	55.4M	27.3M	-10M	-
Net Income to Company	647M	648M	647M	347M	444M
Minority Interest	-100K	1.1M	-2.8M	-1.4M	-1M
Net Income - (IS)	647M	649M	644M	346M	444M
Net Income to Common Incl Extra Items	647M	649M	644M	346M	444M
Net Income to Common Excl. Extra Items	647M	593M	617M	356M	444M
Per Share Items
Net EPS - Basic	7.82	7.87	7.79	4.18	5.37
Basic EPS - Continuing Operations	7.82	7.2	7.46	4.3	5.37
Basic Weighted Average Shares Outstanding	82.65M	82.41M	82.72M	82.76M	82.65M
Net EPS - Diluted	7.76	7.81	7.73	4.15	5.32
Diluted EPS - Continuing Operations	7.76	7.14	7.4	4.27	5.32
Diluted Weighted Average Shares Outstanding	83.36M	83.1M	83.38M	83.39M	83.38M
Normalized Basic EPS	6.63	7.35	6.08	5.89	7.47
Normalized Diluted EPS	6.58	7.29	6.03	5.85	7.4
Dividend Per Share	1.2	1.2	1.2	1.4	1.4
Payout Ratio	12.82	15.31	15.46	28.79	26.2
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	1.09B	1.18B	1.14B	1.19B	1.34B
EBITA	998M	1.1B	1.07B	1.11B	1.29B
EBIT	916M	996M	861M	840M	1.03B
Total Revenues (As Reported)	3B	3.16B	3.31B	3.57B	3.93B
Effective Tax Rate - (Ratio)	20.64	15.94	18.01	17.33	23.11
Total Current Taxes	152M	168M	210M	191M	168M
Total Deferred Taxes	16.2M	-55.4M	-74.1M	-116M	-34.3M
Normalized Net Income	548M	606M	503M	488M	617M
Non-Cash Pension Expense	-2.3M	-600K	1M	900K	800K
Supplemental Operating Expense Items
Selling and Marketing Expenses	836M	833M	917M	957M	944M
General and Administrative Expenses	200M	206M	218M	216M	219M
Research And Development Expense From Footnotes	428M	445M	619M	687M	754M
Stock-Based Comp., Other (Total)	29.9M	27.8M	34.1M	33.5M	39.3M
Total Stock-Based Compensation	29.9M	27.8M	34.1M	33.5M	39.3M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	815M	1.17B	528M	678M	1.53B
Short Term Investments	-	-	-	1.1M	1M
Total Cash And Short Term Investments	815M	1.17B	528M	679M	1.53B
Accounts Receivable, Total	564M	632M	631M	697M	787M
Other Receivables	200M	110M	180M	141M	117M
Total Receivables	764M	743M	811M	838M	904M
Inventory	219M	284M	290M	286M	241M
Prepaid Expenses	68M	77.5M	106M	118M	90.3M
Other Current Assets, Total	87.2M	124M	164M	100M	62.6M
Total Current Assets	1.95B	2.4B	1.9B	2.02B	2.82B
Gross Property Plant And Equipment	1.29B	1.06B	1.13B	1.28B	1.24B
Accumulated Depreciation	-642M	-477M	-556M	-617M	-575M
Net Property Plant And Equipment	648M	581M	575M	664M	668M
Long-term Investments	133M	136M	132M	175M	171M
Goodwill	623M	580M	664M	700M	634M
Other Intangibles, Total	1.39B	1.59B	2.68B	2.52B	2.29B
Deferred Tax Assets Long-Term	253M	321M	325M	285M	298M
Deferred Charges Long-Term	-	-	-	-	25.5M
Other Long-Term Assets, Total	4M	6.2M	50.7M	75.7M	28.9M
Total Assets	5.01B	5.61B	6.32B	6.44B	6.94B
Liabilities
Accounts Payable, Total	595M	647M	771M	855M	854M
Accrued Expenses, Total	254M	249M	278M	279M	282M
Short-term Borrowings	5.5M	3.8M	9M	600K	4M
Current Portion of Long-Term Debt	134M	73.1M	85.1M	85.7M	101M
Current Portion of Leases	29.8M	27.7M	27.4M	36.6M	31.3M
Current Income Taxes Payable	10M	11.8M	41.4M	24.9M	14.3M
Unearned Revenue Current, Total	6M	5.2M	5.7M	5.6M	5.4M
Other Current Liabilities	195M	317M	408M	218M	148M
Total Current Liabilities	1.23B	1.34B	1.63B	1.51B	1.44B
Long-Term Debt	677M	585M	274M	291M	750M
Long-Term Leases	95M	82M	67.4M	102M	83.6M
Unearned Revenue Non Current	45.8M	40.6M	37.7M	36.8M	33.5M
Pension & Other Post Retirement Benefits	40.7M	18.7M	24.4M	24.2M	26M
Deferred Tax Liability Non Current	102M	77.9M	226M	55.2M	52.7M
Other Non Current Liabilities	63.9M	132M	242M	243M	215M
Total Liabilities	2.25B	2.27B	2.5B	2.26B	2.6B
Common Stock, Total	83.8M	83.8M	83.8M	83.8M	83.8M
Additional Paid In Capital	122M	122M	122M	122M	122M
Retained Earnings	647M	649M	644M	346M	444M
Treasury Stock	-123M	-107M	-108M	-114M	-158M
Comprehensive Income and Other	2.02B	2.59B	3.08B	3.74B	3.84B
Total Common Equity	2.75B	3.34B	3.83B	4.18B	4.34B
Minority Interest	2.5M	-600K	-1.3M	200K	900K
Total Equity	2.75B	3.34B	3.82B	4.18B	4.34B
Total Liabilities And Equity	5.01B	5.61B	6.32B	6.44B	6.94B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	82.55M	82.65M	82.72M	82.67M	82.63M
ECS Total Common Shares Outstanding	82.5M	82.64M	82.72M	82.67M	82.63M
Book Value / Share	33.35	40.38	46.24	50.58	52.47
Tangible Book Value	736M	1.17B	482M	964M	1.41B
Tangible Book Value Per Share	8.93	14.18	5.83	11.66	17.11
Total Debt	941M	772M	463M	516M	970M
Net Debt	126M	-398M	-65.5M	-164M	-556M
Debt Equivalent of Unfunded Proj. Benefit Obligation	40.7M	18.7M	24.4M	23.1M	24.3M
Minority Interest, Total (Incl. Fin. Div)	2.5M	-600K	-1.3M	200K	900K
Equity Method Investments, Total	26.2M	26.4M	16.7M	17.3M	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	63.2M	54.8M	66.3M	75.9M	68.2M
Inventories - Work In Process, Total	56.6M	147M	148M	120M	73.2M
Inventories - Finished Goods, Total	118M	104M	104M	149M	141M
Land - (BS)	22.1M	16.8M	17M	17.9M	18M
Buildings, Total	597M	465M	512M	563M	494M
Machinery, Total	412M	295M	282M	299M	325M
Full Time Employees	5.74K	5.07K	5.32K	5.36K	5.54K
Part Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	5.4M	4.6M	3.8M	5.4M	7.9M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	647M	649M	644M	346M	444M
Depreciation & Amortization - CF	128M	126M	110M	117M	76.5M
Amortization of Goodwill and Intangible Assets - (CF)	82.3M	104M	208M	273M	264M
Depreciation & Amortization, Total	210M	230M	318M	390M	341M
Amortization of Deferred Charges, Total - (CF)	20.4M	14.1M	14.7M	15.5M	15.3M
(Gain) Loss From Sale Of Asset	5.8M	-7.5M	16.6M	-82.1M	18.9M
Asset Writedown & Restructuring Costs	9.1M	114M	-230M	249M	347M
(Income) Loss On Equity Investments - (CF)	-400K	1.2M	5.4M	-500K	600K
Stock-Based Compensation (CF)	28.7M	26.5M	30.1M	29.5M	39.3M
Net Cash From Discontinued Operations	-	-55.4M	-27.3M	10M	-
Other Operating Activities, Total	21.2M	38.8M	18M	12M	-67.9M
Change In Accounts Receivable	-67.3M	-86.8M	-1.6M	-45.3M	-132M
Change In Inventories	-500K	-19.9M	-8.9M	-20M	22.7M
Change In Accounts Payable	83.5M	29.1M	110M	58.8M	41.5M
Change In Income Taxes	-32.8M	-	-	-	-
Change in Other Net Operating Assets	-15.1M	38.5M	-22.9M	-48M	68.4M
Cash from Operations	909M	971M	866M	916M	1.14B
Capital Expenditure	-95.9M	-96.6M	-116M	-173M	-105M
Sale of Property, Plant, and Equipment	1.1M	10M	500K	173M	100K
Cash Acquisitions	-	-132M	-910M	-	-341M
Divestitures	14.7M	-	-	-	-
Sale (Purchase) of Real Estate properties	-100K	-	-	-200K	-300K
Sale (Purchase) of Intangible assets	-332M	-156M	-66.7M	-610M	-223M
Investment in Marketable and Equity Securities, Total	-28.4M	-7.8M	-5.7M	-65.2M	-2.4M
Other Investing Activities, Total	96.1M	-76.4M	25.8M	-2.2M	57M
Cash from Investing	-344M	-459M	-1.07B	-677M	-615M
Short Term Debt Issued, Total	-	1.21B	2.6B	200K	400K
Long-Term Debt Issued, Total	30.8M	16M	24.9M	77M	510M
Total Debt Issued	30.8M	1.23B	2.62B	77.2M	511M
Short Term Debt Repaid, Total	-311M	-1.26B	-2.61B	-31.8M	-32M
Long-Term Debt Repaid, Total	-900K	-1.1M	-301M	-1.2M	-1.7M
Total Debt Repaid	-312M	-1.26B	-2.91B	-33M	-33.7M
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-36.7M	-11.3M	-39.5M	-36.5M	-67.7M
Common Dividends Paid	-82.9M	-99.3M	-99.6M	-99.6M	-116M
Common & Preferred Stock Dividends Paid	-82.9M	-99.3M	-99.6M	-99.6M	-116M
Other Financing Activities, Total	-900K	-19.1M	-28.5M	-8.1M	5.4M
Cash from Financing	-401M	-164M	-458M	-100M	298M
Foreign Exchange Rate Adjustments	5.8M	5.9M	5M	19.2M	4.2M
Miscellaneous Cash Flow Adjustments	-100K	1.9M	13.6M	-	18.2M
Net Change in Cash	170M	356M	-646M	158M	844M
Supplemental Items
Cash Interest Paid	-	18.2M	22.6M	8.2M	-
Cash Income Tax Paid (Refund)	-	131M	216M	174M	182M
Levered Free Cash Flow	414M	664M	838M	72.78M	652M
Unlevered Free Cash Flow	428M	679M	855M	87.21M	675M
Change In Net Working Capital	-23.5M	-36.9M	-133M	94.8M	34.5M
Net Debt Issued / Repaid	-281M	-34.5M	-291M	44.2M	477M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	12.28	11.75	9.02	8.22	9.6
Return on Total Capital	16.36	16.32	12.81	11.68	12.83
Return On Equity %	26.46	19.49	17.3	8.93	10.44
Return on Common Equity	26.49	19.54	17.22	8.89	10.41
Margin Analysis
Gross Profit Margin %	82.06	83.28	82.72	82.69	80.89
SG&A Margin	34.5	32.91	34.34	32.85	29.63
EBITDA Margin %	36.3	37.5	34.57	33.33	34.11
EBITA Margin %	33.27	34.87	32.32	31.14	32.87
EBIT Margin %	30.53	31.57	26.04	23.49	26.14
Income From Continuing Operations Margin %	21.56	18.76	18.75	10	11.31
Net Income Margin %	21.56	20.55	19.49	9.68	11.29
Net Avail. For Common Margin %	21.56	18.79	18.66	9.96	11.29
Normalized Net Income Margin	18.28	19.2	15.22	13.64	15.71
Levered Free Cash Flow Margin	13.79	21.03	25.35	2.04	16.59
Unlevered Free Cash Flow Margin	14.29	21.5	25.84	2.44	17.17
Asset Turnover
Asset Turnover	0.64	0.6	0.55	0.56	0.59
Fixed Assets Turnover	4.64	5.14	5.72	5.77	5.9
Receivables Turnover (Average Receivables)	5.51	5.06	4.95	5.12	4.95
Inventory Turnover (Average Inventory)	2.48	2.1	1.99	2.15	2.85
Short Term Liquidity
Current Ratio	1.59	1.8	1.17	1.34	1.96
Quick Ratio	1.29	1.43	0.82	1.01	1.69
Operating Cash Flow to Current Liabilities	0.74	0.73	0.53	0.61	0.79
Days Sales Outstanding (Average Receivables)	66.19	72.2	73.75	71.49	73.68
Days Outstanding Inventory (Average Inventory)	146.98	174.13	183.27	170.07	127.94
Average Days Payable Outstanding	365.97	382.56	448.97	484.13	441.59
Cash Conversion Cycle (Average Days)	-152.8	-136.23	-191.96	-242.56	-239.97
Long Term Solvency
Total Debt/Equity	34.17	23.12	12.11	12.33	22.38
Total Debt / Total Capital	25.47	18.78	10.8	10.98	18.28
LT Debt/Equity	28.04	19.99	8.93	9.39	19.23
Long-Term Debt / Total Capital	20.9	16.24	7.96	8.36	15.72
Total Liabilities / Total Assets	44.99	40.5	39.52	35.06	37.49
EBIT / Interest Expense	38.63	41.87	32.86	36.35	28.45
EBITDA / Interest Expense	47.49	51.53	44.99	53.26	37.89
(EBITDA - Capex) / Interest Expense	43.45	47.47	40.55	45.77	34.98
Total Debt / EBITDA	0.84	0.63	0.39	0.42	0.71
Net Debt / EBITDA	0.11	-0.32	-0.06	-0.13	-0.41
Total Debt / (EBITDA - Capex)	0.91	0.68	0.44	0.49	0.77
Net Debt / (EBITDA - Capex)	0.12	-0.35	-0.06	-0.15	-0.44
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	11.65	14.84	4.75	8.11	9.92
Gross Profit, 1 Yr. Growth %	12.09	13.8	4.05	8.07	10.74
EBITDA, 1 Yr. Growth %	17.1	11.74	1.07	13.05	12.47
EBITA, 1 Yr. Growth %	18.02	13.63	1.98	13.64	16.02
EBIT, 1 Yr. Growth %	20.63	12.44	-8.76	8.77	22.29
Earnings From Cont. Operations, 1 Yr. Growth %	17.82	-6.19	4.7	-42.36	24.41
Net Income, 1 Yr. Growth %	17.99	0.31	-0.65	-46.32	28.22
Normalized Net Income, 1 Yr. Growth %	15.95	14.37	-12.19	8.94	26.63
Diluted EPS Before Extra, 1 Yr. Growth %	18.11	-5.68	3.64	-42.3	24.59
Accounts Receivable, 1 Yr. Growth %	18.5	12.09	-0.19	10.44	12.85
Inventory, 1 Yr. Growth %	2.57	29.49	1.9	-1.38	-15.62
Net Property, Plant and Equip., 1 Yr. Growth %	0.14	-10.21	-1.17	15.59	0.57
Total Assets, 1 Yr. Growth %	16.09	12.37	12.62	1.84	7.75
Tangible Book Value, 1 Yr. Growth %	76.44	57.95	-59.07	99.79	46.7
Common Equity, 1 Yr. Growth %	29.11	22.01	14.39	9.32	3.69
Cash From Operations, 1 Yr. Growth %	17.88	8.74	-10.86	5.73	24.35
Capital Expenditures, 1 Yr. Growth %	20.02	10.15	20.29	48.97	-39.24
Levered Free Cash Flow, 1 Yr. Growth %	-32.97	60.67	42.53	-90.18	1.81K
Unlevered Free Cash Flow, 1 Yr. Growth %	-32.43	58.59	41.73	-88.49	1.29K
Dividend Per Share, 1 Yr. Growth %	20	0	0	16.67	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.53	8.4	9.68	6.42	9.01
Gross Profit, 2 Yr. CAGR %	5.65	9.42	8.81	6.04	7.8
EBITDA, 2 Yr. CAGR %	12.28	12.84	3.88	2.64	12.76
EBITA, 2 Yr. CAGR %	12.7	14.09	5.04	3.07	14.82
EBIT, 2 Yr. CAGR %	14.22	14.58	-1.43	-5.67	15.33
Earnings From Cont. Operations, 2 Yr. CAGR %	244.79	3.86	-0.9	-22.32	-15.32
Net Income, 2 Yr. CAGR %	257.12	8.79	-0.17	-26.97	-17.04
Normalized Net Income, 2 Yr. CAGR %	11.77	13.19	-2.55	-7.76	17.46
Diluted EPS Before Extra, 2 Yr. CAGR %	242.71	4.25	-1.13	-22.67	-15.21
Accounts Receivable, 2 Yr. CAGR %	-0.06	15.25	5.77	4.99	11.64
Inventory, 2 Yr. CAGR %	1.25	15.25	14.87	0.25	-8.78
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.37	-5.18	-5.8	6.88	7.82
Total Assets, 2 Yr. CAGR %	7.82	14.03	12.56	7.09	4.75
Tangible Book Value, 2 Yr. CAGR %	66.75	67.59	-19.37	-9.57	71.2
Common Equity, 2 Yr. CAGR %	25.36	25.14	18.26	11.82	6.47
Cash From Operations, 2 Yr. CAGR %	20.35	12.22	-1.55	-2.92	14.66
Capital Expenditures, 2 Yr. CAGR %	-18.53	9.96	15.11	33.75	-4.86
Levered Free Cash Flow, 2 Yr. CAGR %	26.09	3.7	42.45	-64.82	-6.2
Unlevered Free Cash Flow, 2 Yr. CAGR %	23.94	3.45	41.32	-61.97	-5.63
Dividend Per Share, 2 Yr. CAGR %	9.54	9.54	0	8.01	8.01
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	8.49	5.44	7.17	9.15	7.57
Gross Profit, 3 Yr. CAGR %	9.12	6.04	7.6	8.56	6.53
EBITDA, 3 Yr. CAGR %	17.67	11.08	7.13	4	5.82
EBITA, 3 Yr. CAGR %	16.67	11.89	8.12	4.75	7.22
EBIT, 3 Yr. CAGR %	18.14	12.39	4.29	-1.78	2.86
Earnings From Cont. Operations, 3 Yr. CAGR %	18.66	121.61	4.14	-17.28	-9.12
Net Income, 3 Yr. CAGR %	18.41	133.88	5.55	-18.82	-11.9
Normalized Net Income, 3 Yr. CAGR %	18.08	11.34	2.09	-2.73	2.52
Diluted EPS Before Extra, 3 Yr. CAGR %	18.61	121.09	4.05	-17.38	-9.34
Accounts Receivable, 3 Yr. CAGR %	6.82	3.83	9.85	7.3	7.55
Inventory, 3 Yr. CAGR %	3.39	9.91	10.61	9.18	-5.35
Net Property, Plant and Equip., 3 Yr. CAGR %	10.93	-5.06	-3.86	0.85	4.74
Total Assets, 3 Yr. CAGR %	14.02	9.2	13.6	8.87	7.31
Tangible Book Value, 3 Yr. CAGR %	19.3	64.19	4.95	9.11	6.25
Common Equity, 3 Yr. CAGR %	14.33	23.99	21.53	15.2	9.04
Cash From Operations, 3 Yr. CAGR %	16.78	15.67	3.93	0.82	5.43
Capital Expenditures, 3 Yr. CAGR %	-3.25	-12.56	13.3	25.37	2.82
Levered Free Cash Flow, 3 Yr. CAGR %	18.04	36.64	10.74	-43.94	3.5
Unlevered Free Cash Flow, 3 Yr. CAGR %	18.63	34.49	10.46	-41.15	3.81
Dividend Per Share, 3 Yr. CAGR %	6.27	6.27	6.27	5.27	5.27
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	12.41	9.43	7.08	5.83	7.9
Gross Profit, 5 Yr. CAGR %	13.27	10.08	7.62	6.04	7.68
EBITDA, 5 Yr. CAGR %	22.98	19.44	11.33	6.65	7.59
EBITA, 5 Yr. CAGR %	22.9	19.39	11.2	7.22	8.84
EBIT, 5 Yr. CAGR %	21.33	20	9.17	3.65	6.23
Earnings From Cont. Operations, 5 Yr. CAGR %	23.36	16.95	9.88	45.71	-4.13
Net Income, 5 Yr. CAGR %	23.41	18.96	10.59	46.82	-4.14
Normalized Net Income, 5 Yr. CAGR %	20.61	20.92	8.6	2.12	5.48
Diluted EPS Before Extra, 5 Yr. CAGR %	23.24	17.05	9.74	45.24	-4.13
Accounts Receivable, 5 Yr. CAGR %	9.19	7.67	6.4	4.29	10.56
Inventory, 5 Yr. CAGR %	14.13	11.16	7.84	5.93	2.41
Net Property, Plant and Equip., 5 Yr. CAGR %	11.31	6.79	3.91	-0.45	0.65
Total Assets, 5 Yr. CAGR %	15.62	12.79	13.36	8.38	9.97
Tangible Book Value, 5 Yr. CAGR %	3.44	41.56	2.16	29.48	27.64
Common Equity, 5 Yr. CAGR %	15.15	16.95	15.75	19.02	15.26
Cash From Operations, 5 Yr. CAGR %	23.4	18.1	8.69	7.84	8.1
Capital Expenditures, 5 Yr. CAGR %	3.41	2.71	1.87	3.64	5.62
Levered Free Cash Flow, 5 Yr. CAGR %	43.64	53.14	27.22	-22.49	1.1
Unlevered Free Cash Flow, 5 Yr. CAGR %	45.91	51.67	27.2	-20.75	1.24
Dividend Per Share, 5 Yr. CAGR %	7.14	3.71	3.71	6.96	6.96